John G. Cox
2014
In 2014, John G. Cox earned a total compensation of $4.5M as EVP, Pharmaceutical Operations and Technology at Biogen, a 22% increase compared to previous year.
Compensation breakdown
| Change in Pension Value and Nonqualified Deferred Compensation Earnings | $3,818 |
|---|---|
| Non-Equity Incentive Plan | $709,086 |
| Salary | $609,508 |
| Stock Awards | $2,820,174 |
| Other | $320,831 |
| Total | $4,463,417 |
Cox received $2.8M in stock awards, accounting for 63% of the total pay in 2014.
Cox also received $3.8K of change in pension value and nonqualified deferred compensation earnings, $709.1K in non-equity incentive plan, $609.5K in salary and $320.8K in other compensation.
Rankings
In 2014, John G. Cox's compensation ranked 1,840th out of 13,032 executives tracked by ExecPay. In other words, Cox earned more than 85.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,840 out of 13,032 | 86th |
Division Manufacturing | 650 out of 4,966 | 87th |
Major group Chemicals And Allied Products | 205 out of 1,686 | 88th |
Industry group Drugs | 159 out of 1,365 | 88th |
Industry Biological Products, Except Diagnostic Substances | 23 out of 236 | 90th |
Source: SEC filing on April 15, 2016.
Cox's colleagues
We found seven more compensation records of executives who worked with John G. Cox at Biogen in 2014.
2014
George Scangos
Biogen
Chief Executive Officer
2014
Alfred Sandrock
Biogen
Chief Medical Officer
2014
Adriana Karaboutis
Biogen
EVP, Technology and Business Solutions
2014
Adam Koppel
Biogen
SVP, Chief Strategy Officer
2014
Douglas Williams
Biogen
Former EVP, Research and Development
2014
Paul Clancy
Biogen
Chief Financial Officer
2014
Stuart Kingsley
Biogen